Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
Future Oncology (London, England)
|
April 25, 2020
Recent advances in the management of chemotherapy-induced neutropenia: biosimilar granulocyte colony-stimulating factor use in Italy
Marco Danova, Paolo Pronzato, Ylenia Ingrasciotta, et al.
Autoimmunity Reviews
|
February 4, 2015
The challenging definition of naïve patient for biological drug use
Martina Biggioggero, Marco Danova, Umberto Genovese, et al.
Oncology Reports
|
July 6, 2006
Dose and outcome: the hurdle of neutropenia (Review)
Maurizio Marangolo, Carmelo Bengala, Pier Franco Conte, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 5, 2022
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Vincenzo Adamo, Lorenzo Antonuzzo, Marco Danova, et al.
Tumori
|
July 28, 2006
Sigmoid colon metastasis from sarcomatoid renal cell carcinoma
Roberta Invernizzi, Katia Bencardino, Camillo Porta, et al.
Oncology
|
January 26, 2002
Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study
Silvia Brugnatelli, Marco Danova, Manuela Tamburo De Bella, et al.
Clinical and Experimental Medicine
|
December 17, 2010
Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors
Sara Mariucci, Bianca Rovati, Mariangela Manzoni, et al.
Clinical and Experimental Medicine
|
October 13, 2009
Chemotherapy-induced anemia in breast cancer patients treated with pegfilgrastim-supported dose-dense regimens
Mariangela Manzoni, Sara Delfanti, Bianca Rovati, et al.
Oncology Reports
|
August 9, 2002
Weekly taxanes in metastatic breast cancer (review)
Matteo Zimatore, Marco Danova, Erasmo Vassallo, et al.
Cancer Immunology, Immunotherapy : CII
|
March 29, 2003
Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor
Silvia Ferrari, Bianca Rovati, Camillo Porta, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
Future Oncology (London, England)
|
April 25, 2020
Recent advances in the management of chemotherapy-induced neutropenia: biosimilar granulocyte colony-stimulating factor use in Italy
Marco Danova, Paolo Pronzato, Ylenia Ingrasciotta, et al.
Autoimmunity Reviews
|
February 4, 2015
The challenging definition of naïve patient for biological drug use
Martina Biggioggero, Marco Danova, Umberto Genovese, et al.
Oncology Reports
|
July 6, 2006
Dose and outcome: the hurdle of neutropenia (Review)
Maurizio Marangolo, Carmelo Bengala, Pier Franco Conte, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 5, 2022
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Vincenzo Adamo, Lorenzo Antonuzzo, Marco Danova, et al.
Tumori
|
July 28, 2006
Sigmoid colon metastasis from sarcomatoid renal cell carcinoma
Roberta Invernizzi, Katia Bencardino, Camillo Porta, et al.
Oncology
|
January 26, 2002
Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study
Silvia Brugnatelli, Marco Danova, Manuela Tamburo De Bella, et al.
Clinical and Experimental Medicine
|
December 17, 2010
Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors
Sara Mariucci, Bianca Rovati, Mariangela Manzoni, et al.
Clinical and Experimental Medicine
|
October 13, 2009
Chemotherapy-induced anemia in breast cancer patients treated with pegfilgrastim-supported dose-dense regimens
Mariangela Manzoni, Sara Delfanti, Bianca Rovati, et al.
Oncology Reports
|
August 9, 2002
Weekly taxanes in metastatic breast cancer (review)
Matteo Zimatore, Marco Danova, Erasmo Vassallo, et al.
Cancer Immunology, Immunotherapy : CII
|
March 29, 2003
Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor
Silvia Ferrari, Bianca Rovati, Camillo Porta, et al.
Page
of 8